The group’s long-term goal is to develop specific biomarkers for detecting cancers and to evaluate these biomarkers in pre-clinical cancer models Dr Gabriela Kramer-Marek is investigating new ways of ...

"This innovation could lead to the development of similar imaging agents for other sensory and neurological disorders, broadening the scope of molecular imaging." ...

In the world of nanotechnology, the development of dynamic systems that respond to molecular signals is becoming increasingly ...

Molecular Omics publishes high-quality research in the -omics ... the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques. • studies presenting ...

The US Food and Drug Administration (FDA) has granted fast track designation to Life Molecular Imaging’s (LMI) tau positron ...

Molecular electronics -- the use of single molecules as the building blocks for electronic components -- offers a potential pathway for the continued miniaturization of small-scale electronic devices.

The Division of Radiotherapy and Imaging is investigating new imaging methods to diagnose cancer, and ways in which advances in technology and molecular biology can improve radiation treatment. It is ...

We are pleased with the additional data that support the continued development of our alpha-particle therapies,” said Thijs Spoor, Perspective Therapeutics' CEO. “The data demonstrate the need for ...

New machine learning techniques plumb vast "data lakes" to help researchers design faster, cheaper, more effective clinical ...

Swiss drugmaker Novartis (NOVN.S), opens new tab said on Saturday it had received a binding offer from Germany's Siemens Healthineers (SHLG.DE), opens new tab to acquire its molecular imaging ...

Improved supply capabilities of Neuraceq ® to provide better patient access to beta-amyloid PET BOSTON, Aug. 20, 2024 /PRNewswire/ -- Life Molecular Imaging (LMI) and PharmaLogic Holdings Corp ...

Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany’s Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission ...